SPHK1 and cancer: Despite the vast body of evidence indicating an important role for SPHK1 in cancer cell proliferation and survival, two independent research teams from industry and academia recently described selective SPHK1 inhibitors—“1a” [15] and PF-543 [16]—which do not affect cancer cell proliferation or survival.